Sasinya N. Scott

6.5k total citations · 1 hit paper
29 papers, 2.2k citations indexed

About

Sasinya N. Scott is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, Sasinya N. Scott has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 12 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Sasinya N. Scott's work include Cancer Genomics and Diagnostics (15 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Renal cell carcinoma treatment (5 papers). Sasinya N. Scott is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Renal cell carcinoma treatment (5 papers). Sasinya N. Scott collaborates with scholars based in United States, Switzerland and Canada. Sasinya N. Scott's co-authors include Michael F. Berger, Ronak Shah, David B. Solit, Agnès Viale, A. Rose Brannon, Gopa Iyer, Robert A. Soslow, Irina Ostrovnaya, Bernard H. Bochner and Dean F. Bajorin and has published in prestigious journals such as Science, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Sasinya N. Scott

29 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome Sequencing Identifies a Basis for Everolimus Sensitivity

2012 480 citations Gopa Iyer, Aphrothiti J. Hanrahan et al. Science profile →

Peers

Countries citing papers authored by Sasinya N. Scott

Since Specialization

Citations

This map shows the geographic impact of Sasinya N. Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sasinya N. Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sasinya N. Scott more than expected).

Fields of papers citing papers by Sasinya N. Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sasinya N. Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sasinya N. Scott. The network helps show where Sasinya N. Scott may publish in the future.

Co-authorship network of co-authors of Sasinya N. Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Sasinya N. Scott. A scholar is included among the top collaborators of Sasinya N. Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sasinya N. Scott. Sasinya N. Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Urinary Androgens Provide Additional Evidence Related to Metabolism and Are Correlated With Serum Androgens in Girls 2024 ·Journal of the Endocrine Society ·Sasinya N. Scott, (unknown), Frank Z. Stanczyk, Michaela F. Hartmann, Stefan A. Wudy, Melissa White, Wendy K. Chung, Regina M. Santella, Mary Beth Terry, Lauren C. Houghton	3
2	A phase 2 trial of buparlisib in patients with platinum‐resistant metastatic urothelial carcinoma 2020 ·Cancer ·Victor McPherson, Brendan Reardon, (unknown), Sasinya N. Scott, Mariel Elena Boyd, Ilana Garcia-Grossman, Ashley Marie Regazzi, Asia S. McCoy, Philip H. Kim, Hikmat Al‐Ahmadie, Irina Ostrovnaya, Andrew Roth, Azeez Farooki, Michael F. Berger, Jonathan E. Rosenberg, David B. Solit, Eliezer M. Van Allen, Matthew I. Milowsky, Dean F. Bajorin, Gopa Iyer	20
3	The repertoire of genetic alterations in salivary duct carcinoma including a novel HNRNPH3-ALK rearrangement 2019 ·Human Pathology ·Snjezana Doğan, Charlotte K.Y. Ng, Bin Xu, Rahul Kumar, Lu Wang, Marcia Edelweiss, Sasinya N. Scott, Ahmet Zehir, Alexander Drilon, Luc G.T. Morris, Nancy Y. Lee, Cristina R. Antonescu, Alan L. Ho, Nora Katabi, Michael F. Berger, Jorge S. Reis‐Filho	37
4	Next‐generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non–muscle‐invasive urothelial carcinoma treated with bacille Calmette‐Guérin 2017 ·Cancer Cytopathology ·Sasinya N. Scott, Irina Ostrovnaya, (unknown), Nancy Bouvier, Bernard H. Bochner, Gopa Iyer, David B. Solit, Michael F. Berger, Oscar Lin	23
5	The genetic landscape of endometrial clear cell carcinomas 2017 ·The Journal of Pathology ·Deborah F. DeLair, Kathleen A. Burke, Pier Selenica, Raymond S. Lim, Sasinya N. Scott, Sumit Middha, Abhinita Mohanty, Donavan T. Cheng, Michael F. Berger, Robert A. Soslow, Britta Weigelt	169
6	The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypes 2016 ·Modern Pathology ·Olca Baştürk, Marcus Tan, Umesh Bhanot, Peter J. Allen, Volkan Adsay, Sasinya N. Scott, Ronak Shah, Michael F. Berger, Gokce Askan, Esra Dikoglu, Vaidehi Jobanputra, Kazimierz O. Wrzeszczyński, Carlie Sigel, Christine A. Iacobuzio–Donahue, David S. Klimstra	68
7	NF1 Mutations Are Common in Desmoplastic Melanoma 2015 ·The American Journal of Surgical Pathology ·Thomas Wiesner, Maija Kiuru, Sasinya N. Scott, Maria E. Arcila, Allan C. Halpern, Travis J. Hollmann, Michael F. Berger, Klaus J. Busam	79
8	GNAS and KRAS Mutations Define Separate Progression Pathways in Intraductal Papillary Mucinous Neoplasm-Associated Carcinoma 2015 ·Journal of the American College of Surgeons ·Marcus Tan, Olca Baştürk, (unknown), Umesh Bhanot, Sasinya N. Scott, Nancy Bouvier, Jennifer LaFemina, William R. Jarnagin, Michael F. Berger, David S. Klimstra, Peter J. Allen	131
9	Comprehensive mutation profiling by next‐generation sequencing of effusion fluids from patients with high‐grade serous ovarian carcinoma 2015 ·Cancer Cytopathology ·Ronak Shah, Sasinya N. Scott, A. Rose Brannon, Douglas A. Levine, Oscar Lin, Michael F. Berger	24
10	Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma 2015 ·Modern Pathology ·Melissa Pulitzer, A. Rose Brannon, Michael F. Berger, (unknown), Sasinya N. Scott, Achim A. Jungbluth, Daniel G. Coit, Isaac Brownell, Klaus J. Busam	60
11	Phase 2 study of the pan-isoform PI3 kinase inhibitor BKM120 in metastatic urothelial carcinoma patients. 2015 ·Journal of Clinical Oncology ·Gopa Iyer, (unknown), Ilana Garcia-Grossman, Sasinya N. Scott, Mariel Elena Boyd, Asia S. McCoy, Michael F. Berger, Hikmat Al‐Ahmadie, David B. Solit, Jonathan E. Rosenberg, Dean F. Bajorin	7
12	Tumor Genetic Analyses of Patients with Metastatic Renal Cell Carcinoma and Extended Benefit from mTOR Inhibitor Therapy 2014 ·Clinical Cancer Research ·Martin H. Voss, A. Ari Hakimi, Can G. Pham, A. Rose Brannon, Ying‐Bei Chen, Luis F. Cunha, Oğuz Akın, Han Liu, Shugaku Takeda, Sasinya N. Scott, Nicholas D. Socci, Agnès Viale, Nikolaus Schultz, Chris Sander, Victor E. Reuter, Paul Russo, Emily H. Cheng, Robert J. Motzer, Michael F. Berger, James J. Hsieh	156
13	Genomic Predictors of Survival in Patients with High-grade Urothelial Carcinoma of the Bladder 2014 ·European Urology ·Philip H. Kim, K. Eugene, John P. Sfakianos, Gopa Iyer, Emily C. Zabor, Sasinya N. Scott, Irina Ostrovnaya, Ricardo J. Ramirez, Arony Sun, Ronak Shah, (unknown), Victor E. Reuter, Dean F. Bajorin, Jonathan E. Rosenberg, Nikolaus Schultz, Michael F. Berger, Hikmat Al‐Ahmadie, David B. Solit, Bernard H. Bochner	105
14	Recurrent SMARCA4 mutations in small cell carcinoma of the ovary 2014 ·Nature Genetics ·Petar Jelinic, Jennifer J. Mueller, Narciso Olvera, Fanny Dao, Sasinya N. Scott, Ronak Shah, (unknown), Nikolaus Schultz, Mithat Gönen, Robert A. Soslow, Michael F. Berger, Douglas A. Levine	266
15	Branched evolution and intratumor heterogeneity of urothelial carcinoma of the bladder. 2014 ·Journal of Clinical Oncology ·K. Eugene, John P. Sfakianos, Hikmat Al‐Ahmadie, Sasinya N. Scott, Philip H. Kim, Gopa Iyer, Dean F. Bajorin, Jonathan E. Rosenberg, Michael F. Berger, Bernard H. Bochner, David B. Solit	6
16	Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions 2014 ·Genome Biology ·A. Rose Brannon, (unknown), Brooke E. Sylvester, Sasinya N. Scott, (unknown), Ronak Shah, (unknown), Agnès Viale, Dayna M. Oschwald, Vladimir Vacic, Anne‐Katrin Emde, Andrea Cercek, Rona Yaeger, Nancy E. Kemeny, Leonard B. Saltz, Jinru Shia, Michael I. D’Angelica, Martin R. Weiser, David B. Solit, Michael F. Berger	14
17	Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma 2013 ·Clinical Cancer Research ·Federica Catalanotti, David B. Solit, Melissa Pulitzer, Michael F. Berger, Sasinya N. Scott, Tunç Iyriboz, Mario E. Lacouture, Katherine S. Panageas, Jedd D. Wolchok, Richard D. Carvajal, Gary K. Schwartz, Neal Rosen, Paul B. Chapman	112
18	Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing 2013 ·Journal of Visualized Experiments ·Helen Won, Sasinya N. Scott, A. Rose Brannon, Ronak Shah, Michael F. Berger	44
19	Genome Sequencing Identifies a Basis for Everolimus Sensitivity breakdown → 2012 ·Science ·Gopa Iyer, Aphrothiti J. Hanrahan, Matthew I. Milowsky, Hikmat Al‐Ahmadie, Sasinya N. Scott, Manickam Janakiraman, Mono Pirun, Chris Sander, Nicholas D. Socci, Irina Ostrovnaya, Agnès Viale, Adriana Heguy, (unknown), Timothy A. Chan, Bernard H. Bochner, Dean F. Bajorin, Michael F. Berger, Barry S. Taylor, David B. Solit	480
20	Genetic determinants of long-term response to rapalog therapy in advanced renal cell carcinoma (RCC). 2012 ·Journal of Clinical Oncology ·Martin H. Voss, A. Ari Hakimi, Sasinya N. Scott, Shugaku Takeda, Han Liu, Ying‐Bei Chen, Robert J. Motzer, Michael F. Berger, James J. Hsieh	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact